Development of Rapid Immunofiltration Sero Diagnostics Assay

Hepatitis C virus (HCV) has been identified as a causative agent for the majority of parenterally transmitted non-A, non-B hepatitis(Kazuaki Takahashi et al,1992) .The hepatitis C virus (HCV) is a prevalent infectious disease(Xie Li et al,2007). Hepatitis C virus (HCV) is the most common chronic blood born infection in,and is involved in 40% of chronic liver disease. HCV was initially isolated from the serum of a person with non-A, non-B hepatitis in 1989 by Choo et al. This newly found virus was discovered to be the cause of approximately 90% of non-A, non-B hepatitis. Hepatitis C virus (HCV) infection afflicts more than 170-200 million people worldwide, with the great majority of patients with acute hepatitis C developing chronic HCV infection. It can ultimately result in liver cirrhosis, hepatic failure or hepatocellular carcinoma, which are responsible for hundreds of thousands of deaths each year (Stéphane Chevaliez et al). Chronic hepatitis C is the most common cause of chronic liver disease and cirrhosis, and the most common indication for liver transplantation in the United States (U.S.), Australia, and most of Europe.

Autorentext

Candidat au doctorat en biotechnologie Chercheur en doctorat Département de biotechnologie, Université agricole de Junagadh, Junagadh, Gujarat, Inde.